SCHEMBL9060482

SCHEMBL9060482

Cc1cccc(CN2CCOCC2)c1[N+](=O)[O-]

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A13 Q16696 5/20 0.61
CTSB P07858 1/20 0.50
ALDH1A1 P00352 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
LMNA P02545 1/20 0.49
MAPT P10636 1/20 0.49
KCNJ1 P48048 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
POLB P06746 2/20 0.44
KDM4E B2RXH2 1/20 0.44
TSHR P16473 1/20 0.44
MCL1 Q07820 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
ACHE P22303 1/20 0.43
CYP2C9 P11712 1/20 0.43
ALOX15 P16050 1/20 0.43
HSD17B10 Q99714 1/20 0.43
CXCR4 P61073 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3766430 0.83 CYP2A13 (0.50) CYP2A13CTSBALDH1A1SMN1; SMN2LMNA
SCHEMBL3774742 0.83 CTSB (0.53) CYP2A13CTSBALDH1A1SMN1; SMN2LMNA
SCHEMBL28814466 0.83 CTSB (0.50) CYP2A13CTSBALDH1A1SMN1; SMN2LMNA
SCHEMBL28795439 0.82 CTSB (0.46) CYP2A13CTSBALDH1A1SMN1; SMN2LMNA
SCHEMBL28795437 0.81 CTSB (0.48) CYP2A13CTSBALDH1A1SMN1; SMN2LMNA
SCHEMBL3721123 0.81 CYP2A13 (0.54) CYP2A13CTSBALDH1A1SMN1; SMN2LMNA
SCHEMBL2141932 0.79 HCRTR1 (0.52) CYP2A13CTSBALDH1A1SMN1; SMN2LMNA
SCHEMBL28852963 0.77 CYP2A13 (0.75) CYP2A13ALDH1A1SMN1; SMN2LMNAMEN1
SCHEMBL4108854 0.77 CYP2A13 (1.00) CYP2A13ALDH1A1LMNAMAPTTDP1
SCHEMBL9059147 0.77 ALDH1A1 (0.55) CTSBALDH1A1LMNAMAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996017612-A1 USE OF SUBSTITUTED PHENYLAMIDINE AND PHENYLGUANIDINE COMPOUNDS FOR THE TREATMENT OF CEREBRAL AND CARDIAC ISCHAEMIA, CONVULSION AND SICKLE CELL ANAEMIA KNOLL AKTIENGESELLSCHAFT (DE) 1996-06-13 WO disclosed